Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06871098 · ClinicalTrials.gov registry record · NA
Improving Mechanics and Confidence in the Hip Hinge
A NA study of Hip Hinge and Hip and Knee Movement, sponsored by University of Central Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06871098: Recruiting NA study of Hip Hinge and Hip and Knee Movement, sponsored by University of Central Florida.
NCT06871098 is a NA study of Hip Hinge and Hip and Knee Movement that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06871098, a NA study of Hip Hinge and Hip and Knee Movement, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate if the Founder exercise will significantly change participants kinematics when performing hip hinge movement. Secondary purpose is to evaluate if completing the Founder Exercise intervention will improve confidence in performing a hip hinge.
Primary Outcome
The angles will be measured using 2D video analysis through the OnForm app on an iPad. This will be recorded directly into the app and stored by OnForm (OnForm's privacy policy is attached). This app enables video recording and allows for detailed frame-by-frame analysis, including precise marking of anatomical structures and the calculation of distances and angles during the participant's hip hinge movement. The iPad will be positioned to the left of the participant so that all reflective marke
Conditions Studied
Interventions
- OTHER Hip Hinge Instruction
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2026-03-23 |
| Phase | NA |
What NCT06871098 shows while recruiting
NCT06871098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Hip Hinge appearing as the primary indexed condition, and to 1 intervention - of which Hip Hinge Instruction is the first listed.
NCT06871098 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06871098 about?
NCT06871098 is a clinical study titled "Improving Mechanics and Confidence in the Hip Hinge". To evaluate if the Founder exercise will significantly change participants kinematics when performing hip hinge movement. Secondary purpose is to evaluate if completing the Founder Exercise intervention will improve confidence in performing a hip hinge.
What is the current status of trial NCT06871098?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-03. Estimated completion is 2026-03-23.
What conditions does trial NCT06871098 study?
This clinical trial studies the following conditions: Hip Hinge, Hip and Knee Movement.
What interventions are being tested in trial NCT06871098?
The interventions under investigation include: Hip Hinge Instruction (OTHER).
Who is sponsoring clinical trial NCT06871098?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06871098 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06871098's enrollment target sits among peer trials
30 1594th of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI